Content about Herpes labialis

December 6, 2012

The consumer health division of GlaxoSmithKline has enlisted an Olympic gold medalist to educate the public about cold sores and promote its OTC cold sore treatment.

PARSIPPANY, N.J. — The consumer health division of GlaxoSmithKline has enlisted an Olympic gold medalist to educate the public about cold sores and promote its OTC cold sore treatment.

October 4, 2012

GlaxoSmithKline Consumer Healthcare recently introduced Abreva Conceal, a clear nonmedicated patch that covers cold sores.

PARSIPPANY, N.J. — GlaxoSmithKline Consumer Healthcare recently introduced Abreva Conceal, a clear nonmedicated patch that covers cold sores.

Abreva Conceal uses MicroAir technology, which allows air in while keeping contaminants out. Once the cold sore blister has appeared, Abreva Conceal can be placed over it, creating a covered, protected environment for up to eight hours and provides a smooth surface so that makeup can be applied on top of the patch. GSK said the product delivers true product innovation and will drive significant growth in the cold sore category.

August 18, 2011

Forces of Nature on Wednesday introduced its brand called Control, featuring 14 USDA-certified organic and Food and Drug Administration-registered topical medicines that target seven hard-to-treat conditions, including acne, herpes cold sores (caused by the herpes simplex virus) and scars.

SONOMA, Calif. — Forces of Nature on Wednesday introduced its brand called Control, featuring 14 USDA-certified organic and Food and Drug Administration-registered topical medicines that target seven hard-to-treat conditions, including acne, herpes cold sores (caused by the herpes simplex virus) and scars. Each medicine uses a two-in-one approach that merges botanicals with recognized and established homeopathic drugs. The Control line is currently available at select Whole Foods Market stores and is rolling out in independent natural retailers nationwide.

March 24, 2011

Sandoz has introduced an authorized generic version of a herpes treatment made by parent company Novartis, the company said Thursday.

PRINCETON — Sandoz has introduced an authorized generic version of a herpes treatment made by parent company Novartis, the company said Thursday.

Sandoz announced the launch of famciclovir tablets, an authorized generic of Famvir, used to treat genital herpes and cold sores in patients with healthy immune systems, and to treat shingles and herpes simplex infections of the skin and mucosa in patients with HIV.

Authorized generics are branded drugs sold under their generic chemical names at a reduced price, often through third-party companies.

March 22, 2011

A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections, the company said Monday.

MORRISTOWN, N.J. — A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections, the company said Monday.

Watson Labs launched famciclovir tablets in the 125-mg, 250-mg and 500-mg strengths. The drug is a generic version of Novartis’ Famvir and is used to treat cold sores and genital herpes in patients with and without HIV.

Famvir and generic versions had sales of about $197 million in 2010, according to IMS Health.

March 1, 2011

Meda has launched a new cold sore treatment made by commercialization partner Medivir, Medivir said Tuesday.

HUDDINGE, Sweden — Meda has launched a new cold sore treatment made by commercialization partner Medivir, Medivir said Tuesday.

The Swedish drug maker launched Xerese (acyclovir and hydrocortisone), a topical combination product designed to treat recurrent herpes simplex labialis.

Medivir said the U.S. market for cold sore products is $230 million, and it expected the drug to be successful, given Meda’s presence in the U.S. market.

June 23, 2010

GlaxoSmithKline on Wednesday announced an exclusive agreement for the over-the-counter rights to Medivir’s cold sore...

February 17, 2010

Meda plans to work with Medivir to commercialize a cold-sore drug in North America, the...